Daniel Bauer, MD, PhD

Boston Children’s Hospital · company speakers →

Dr. Bauer will show how CRISPR-Cas9 technology is being used to better understand the mechanisms of BCL11A gene expression and identify new DNA targets for genome editing-mediated induction of gamma globin.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

ASH Meeting on Hematologic Malignancies

21 August 2026 Chicago, United States “Editing the Genome to Reinstate Fetal Hemoglobin Expression”

Sourcing speakers for your event?

Browse the speaker directory →